Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-25T06:16:31.975Z Has data issue: false hasContentIssue false

EPA-0050 - Different Distribution Patterns of lymphocytes and Microglia in the Hippocampus of Patients with Residual Versus Paranoid Schizophrenia: Further Evidence for Disease Course-related Immune Alterations?

Published online by Cambridge University Press:  15 April 2020

J. Steiner
Affiliation:
Psychiatry, Medical Faculty of Otto-von-Guericke University Magdeburg, Magdeburg, Germany
H.G. Bernstein
Affiliation:
Psychiatry, Medical Faculty of Otto-von-Guericke University Magdeburg, Magdeburg, Germany
B. Bogerts
Affiliation:
Psychiatry, Medical Faculty of Otto-von-Guericke University Magdeburg, Magdeburg, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Based on the neuroinflammatory hypothesis of schizophrenia, we have quantified the numerical density of immunostained CD3+ T-lymphocytes, CD20+ B-lymphocytes, and HLA-DR+ microglial cells in the posterior hippocampus of 17 schizophrenia patients and 11 matched controls. Disease course-related immune alterations were considered by a separate analysis of residual (prevailing negative symptoms, n=7) and paranoid (prominent positive symptoms, n=10) schizophrenia cases. Higher lymphocyte densities were observed in residual schizophrenia. In contrast, HLA-DR+ microglia were increased in paranoid schizophrenia. BBB impairment and infiltration of T cells and B cells may contribute to the pathophysiology of residual schizophrenia, while microglial activation seems to play a role in paranoid schizophrenia. The identification of diverse immune endophenotypes may facilitate the development of distinct anti-inflammatory schizophrenia therapies to normalize BBB function, (auto)antibody production or microglial activity.

Type
S514 - Symposium: The involvement of Microglia and immune-related proteins in the pathophysiology and treatment of schizophrenia
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.